Caladrius BiosciencesRecent Data Breaches and Security Report

https://caladrius.com  ᛫  Biotech & Pharmaceuticals
Last updated October 26, 2018

Company Details

Company Overview

Caladrius Biosciences (NASDAQ: CLBS) is an American biopharmaceutical company active in the field of stem cell therapy and regenerative medicine, particularly (in 2012) of cardiovascular disease. The company was founded in 1980 and was formerly known as Corniche Group Inc, Phase III Medical Inc and NeoStem, Inc.

Valuation

Employees

CEO

David J. Mazzo

Location

Recent Data Breaches

Stay informed about the most recent data breaches affecting companies like Caladrius Biosciences

subscribe to data breach notifications

Security Rating

Sorry, this security report couldn't be loaded at this time. Please try again later.

UpGuard's CSTAR Score ranges from 0 to 950. The higher the score, the more effective a company is in implementing good security practices.

Passed Checks

Passed{{ passedCheck.passTitle }}

Failed Checks

Warning{{ failedCheck.failTitle }}

View a free security report for Caladrius Biosciences

Get full security report ›

See UpGuard In Action

Book a call with one of our specialists and we'll arrange a time for a demo.